G.J. Lockbaum

729 total citations
21 papers, 448 citations indexed

About

G.J. Lockbaum is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, G.J. Lockbaum has authored 21 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 9 papers in Molecular Biology and 7 papers in Virology. Recurrent topics in G.J. Lockbaum's work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (7 papers) and Hepatitis C virus research (7 papers). G.J. Lockbaum is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (7 papers) and Hepatitis C virus research (7 papers). G.J. Lockbaum collaborates with scholars based in United States. G.J. Lockbaum's co-authors include Celia A. Schiffer, Neşe Kurt Yılmaz, E.A. Nalivaika, Akbar Ali, M. Henes, Paul R. Thompson, Archie C. Reyes, L.N. Rusere, Florian Leidner and Ronak Tilvawala and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

G.J. Lockbaum

20 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.J. Lockbaum United States 13 250 167 164 87 86 21 448
M. Henes United States 11 138 0.6× 44 0.3× 102 0.6× 84 1.0× 46 0.5× 16 268
Tianhong Zhang China 12 174 0.7× 49 0.3× 159 1.0× 70 0.8× 62 0.7× 13 420
Mira A. M. Behnam Germany 13 311 1.2× 119 0.7× 237 1.4× 97 1.1× 140 1.6× 19 910
Daniel Brian Nichols United States 12 339 1.4× 129 0.8× 214 1.3× 67 0.8× 97 1.1× 18 701
Usman Bacha United States 8 410 1.6× 267 1.6× 209 1.3× 101 1.2× 85 1.0× 8 549
Ling Ma China 13 199 0.8× 69 0.4× 125 0.8× 97 1.1× 125 1.5× 41 438
Anna Offersgaard Denmark 11 226 0.9× 97 0.6× 94 0.6× 18 0.2× 28 0.3× 18 406
Shoaib Saleem Pakistan 11 261 1.0× 173 1.0× 387 2.4× 20 0.2× 25 0.3× 16 573
Ashleigh Shannon France 10 487 1.9× 93 0.6× 177 1.1× 29 0.3× 22 0.3× 16 673
C. S. Brian Chia Singapore 17 209 0.8× 96 0.6× 405 2.5× 46 0.5× 109 1.3× 41 931

Countries citing papers authored by G.J. Lockbaum

Since Specialization
Citations

This map shows the geographic impact of G.J. Lockbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.J. Lockbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.J. Lockbaum more than expected).

Fields of papers citing papers by G.J. Lockbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.J. Lockbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.J. Lockbaum. The network helps show where G.J. Lockbaum may publish in the future.

Co-authorship network of co-authors of G.J. Lockbaum

This figure shows the co-authorship network connecting the top 25 collaborators of G.J. Lockbaum. A scholar is included among the top collaborators of G.J. Lockbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.J. Lockbaum. G.J. Lockbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sparling, Brian A., Hyelee Lee, Simina Grigoriu, et al.. (2025). Discovery of Kinesin KIF18A Inhibitor ATX020: Tactical Application of Silicon Atom Replacement. ACS Medicinal Chemistry Letters. 16(11). 2309–2319.
2.
Lockbaum, G.J., L.N. Rusere, M. Henes, et al.. (2023). HIV-1 protease inhibitors with a P1 phosphonate modification maintain potency against drug-resistant variants by increased interactions with flap residues. European Journal of Medicinal Chemistry. 257. 115501–115501. 6 indexed citations
3.
Lockbaum, G.J., E. Allen Sickmier, Brian A. Sparling, et al.. (2023). Abstract B073: Characterization of selective, allosteric inhibitors of human XRN1. Molecular Cancer Therapeutics. 22(12_Supplement). B073–B073. 3 indexed citations
4.
Lee, Sook-Kyung, Shuntai Zhou, G.J. Lockbaum, et al.. (2023). Selection of HIV-1 for resistance to fifth-generation protease inhibitors reveals two independent pathways to high-level resistance. eLife. 12. 13 indexed citations
5.
Buker, Shane M., Stephen J. Blakemore, P. Ann Boriack‐Sjodin, et al.. (2023). Abstract A170: Discovery of small molecule inhibitors of ADAR1. Molecular Cancer Therapeutics. 22(12_Supplement). A170–A170. 2 indexed citations
6.
Shaqra, Ala M., Sarah N. Zvornicanin, Qiu Yu J. Huang, et al.. (2022). Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance. Nature Communications. 13(1). 3556–3556. 73 indexed citations
7.
Mondal, Santanu, Yongzhi Chen, G.J. Lockbaum, et al.. (2022). Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2. Journal of the American Chemical Society. 144(46). 21035–21045. 31 indexed citations
8.
Lockbaum, G.J., Archie C. Reyes, Ronak Tilvawala, et al.. (2021). Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188. Viruses. 13(2). 174–174. 84 indexed citations
9.
Lockbaum, G.J., M. Henes, Nathaniel Talledge, et al.. (2021). Inhibiting HTLV-1 Protease: A Viable Antiviral Target. ACS Chemical Biology. 16(3). 529–538. 15 indexed citations
10.
Lockbaum, G.J., M. Henes, Jeong Min Lee, et al.. (2021). Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode. Biochemistry. 60(39). 2925–2931. 28 indexed citations
11.
Leidner, Florian, G.J. Lockbaum, M. Henes, et al.. (2021). Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond. Chemical Reviews. 121(6). 3238–3270. 50 indexed citations
12.
Harshbarger, Wayne, G.J. Lockbaum, Shurong Hou, et al.. (2021). Unique structural solution from a VH3-30 antibody targeting the hemagglutinin stem of influenza A viruses. Nature Communications. 12(1). 559–559. 11 indexed citations
13.
Rusere, L.N., G.J. Lockbaum, M. Henes, et al.. (2020). Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere. Journal of Medicinal Chemistry. 63(15). 8296–8313. 5 indexed citations
14.
Lockbaum, G.J., Florian Leidner, William E. Royer, Neşe Kurt Yılmaz, & Celia A. Schiffer. (2020). Optimizing the refinement of merohedrally twinned P61 HIV-1 protease–inhibitor cocrystal structures. Acta Crystallographica Section D Structural Biology. 76(3). 302–310. 1 indexed citations
15.
Rao, Desaboini Nageswara, M. Henes, G.J. Lockbaum, et al.. (2020). Avoiding Drug Resistance by Substrate Envelope Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors. The FASEB Journal. 34(S1). 1–1. 2 indexed citations
16.
Henes, M., G.J. Lockbaum, Florian Leidner, et al.. (2019). Molecular Determinants of Epistasis in HIV-1 Protease: Elucidating the Interdependence of L89V and L90M Mutations in Resistance. Biochemistry. 58(35). 3711–3726. 12 indexed citations
17.
Henes, M., G.J. Lockbaum, Florian Leidner, et al.. (2019). Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance. ACS Chemical Biology. 14(11). 2441–2452. 32 indexed citations
18.
Rusere, L.N., G.J. Lockbaum, Sook-Kyung Lee, et al.. (2019). HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2′ Ligands To Optimize Hydrogen Bonding in the Substrate Envelope. Journal of Medicinal Chemistry. 62(17). 8062–8079. 22 indexed citations
19.
Lockbaum, G.J., Florian Leidner, L.N. Rusere, et al.. (2018). Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease. ACS Infectious Diseases. 5(2). 316–325. 27 indexed citations
20.
Rusere, L.N., G.J. Lockbaum, Muhammad Jahangir, et al.. (2018). Quinoxaline-Based Linear HCV NS3/4A Protease Inhibitors Exhibit Potent Activity against Drug Resistant Variants. ACS Medicinal Chemistry Letters. 9(7). 691–696. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Henes Breakdown of academic impact, for papers by Tianhong Zhang Breakdown of academic impact, for papers by Mira A. M. Behnam Breakdown of academic impact, for papers by Daniel Brian Nichols Breakdown of academic impact, for papers by Usman Bacha Breakdown of academic impact, for papers by Ling Ma Breakdown of academic impact, for papers by Anna Offersgaard Breakdown of academic impact, for papers by Shoaib Saleem Breakdown of academic impact, for papers by Ashleigh Shannon Breakdown of academic impact, for papers by C. S. Brian Chia
Rankless by CCL
2026